The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Transfer of Genes to Humans: Early Lessons and Obstacles to Success
Abstract
Enough information has been gained from clinical trials to allow the conclusion that human gene transfer is feasible, can evoke biologic responses that are relevant to human disease, and can provide important insights into human biology. Adverse events have been uncommon and have been related to the gene delivery strategies, not to the genetic material being transferred. Human gene transfer still faces significant hurdles before it becomes an established therapeutic strategy. However, its accomplishments to date are impressive, and the logic of the potential usefulness of this clinical paradigm continues to be compelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years
Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., et al. (1995) · Science · doi:10.1126/science.270.5235.475 · Cited by 1,550
Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230904 · Cited by 1,318
Rooney, C. M., Ng, C. Y. C., Loftin, S., Smith, C. A., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91150-2 · Cited by 1,173
Yang, Y., Li, Q., Ertl, H. C., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,032
Cited by
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Synthetic DNA delivery systems
Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/71889 · Cited by 1,626
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Rädler, J. O., Koltover, I., Salditt, T., & Safinya, C. R. (1997) · Science · doi:10.1126/science.275.5301.810 · Cited by 1,410
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Henry, S., McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980042+ · Cited by 1,346
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Development of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196
THE ROLE OF GROWTH FACTORS IN THE REPAIR OF BONE: BIOLOGY AND CLINICAL APPLICATIONS
LIEBERMAN, J. R., DALUISKI, A., & EINHORN, T. A. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200206000-00022 · Cited by 932
Degradable poly (β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA
Lynn, D. M., & Langer, R. (2000) · Journal of the American Chemical Society · doi:10.1021/ja0015388 · Cited by 924
Heslop, H. E., Ng, C. Y. C., Li, C., Smith, C. A., Loftin, S. K., Krance, R. A., Brenner, M. K., & Rooney, C. M. (1996) · Nature Medicine · doi:10.1038/nm0596-551 · Cited by 821
Pollard, H., Remy, J.-S., Loussouarn, G., Demolombe, S., Behr, J.-P., & Escande, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7507 · Cited by 711
Immune responses to adenovirus and adeno-associated virus in humans
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300994 · Cited by 684
The forthcoming applications of gold nanoparticles in drug and gene delivery systems
Pissuwan, D., Niidome, T., & Cortie, M. B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.006 · Cited by 669
Polymer–drug conjugates: Progress in polymeric prodrugs
Khandare, J., & Minko, T. (2006) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.09.004 · Cited by 639
Gene Therapy for Cancer: What Have We Done and Where Are We Going?
Roth, J. A., & Cristiano, R. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.21 · Cited by 635
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
Kafri, T., Blömer, U., Peterson, D. A., Gage, F. H., & Verma, I. M. (1997) · Nature Genetics · doi:10.1038/ng1197-314 · Cited by 605
Inorganic Nanoparticles as Carriers of Nucleic Acids into Cells
Sokolova, V., & Epple, M. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703039 · Cited by 581
DNA-polycation nanospheres as non-viral gene delivery vehicles
Leong, K. W., Mao, H.-Q., Truong-Le, V. L., Roy, K., Walsh, S. M., & August, J. T. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00252-6 · Cited by 538
Viral Vectors for Gene Therapy
Robbins, P. D., & Ghivizzani, S. C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00020-5 · Cited by 529
LIEBERMAN, J. R., DALUISKI, A., STEVENSON, S., JOLLA, L., WU, L., McALLISTER, P., LEE, Y. P., KABO, J. M., FINERMAN, G. A. M., BERK, A. J., et al. (1999) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199907000-00002 · Cited by 527
Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Self-citationJooss, K., Yang, Y., Fisher, K. J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4212-4223.1998 · Cited by 470
“While this has been exploited for the development of vaccines for cancer (5, 29, 32–35, 43) and infectious disease (25, 37, 40), it is a substantial problem in the treatment of chronic diseases, such as autosomal recessive disorders, where prolonged transgene expression may be desired (4, 44).”
BackgroundMuruve, D. A., Barnes, M. J., Stillman, I. E., & Libermann, T. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950018364 · Cited by 447
In vivo electrically mediated protein and gene transfer in murine melanoma
Rols, M.-P., Delteil, C., Golzio, M., Dumond, P., Cros, S., & Teissie, J. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-168 · Cited by 421
Direct visualization at the single-cell level of electrically mediated gene delivery
Golzio, M., Teissié, J., & Rols, M.-P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022646499 · Cited by 411
Huang, M., Fong, C.-W., Khor, E., & Lim, L.-Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.004 · Cited by 374
Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles
Cohen, H., Levy, R. J., Gao, J., Fishbein, I., Kousaev, V, Sosnowski, S., Slomkowski, S., & Golomb, G. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301318 · Cited by 360
Sterman, D. H., Treat, J., Litzky, L. A., Amin, K. M., Coonrod, L., Molnar-Kimber, K., Recio, A., Knox, L., Wilson, J. M., Albelda, S. M., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.7-1083 · Cited by 341
Microfabricated Microneedles for Gene and Drug Delivery
McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (2000) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.2.1.289 · Cited by 335
Basic science of anterior cruciate ligament injury and repair
Kiapour, A. M., & Murray, M. M. (2014) · Bone & Joint Research · doi:10.1302/2046-3758.32.2000241 · Cited by 328
Hong, K., Zheng, W., Baker, A., & Papahadjopoulos, D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01397-x · Cited by 317
Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles
Reiser, J., Harmison, G., Kluepfel-Stahl, S., Brady, R. O., Karlsson, S., & Schubert, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15266 · Cited by 307
Lieberman, J. R., Le, L. Q., Wu, L., Finerman, G. A. M., Berk, A., Witte, O. N., & Stevenson, S. (1998) · Journal of Orthopaedic Research · doi:10.1002/jor.1100160309 · Cited by 306
Mack, C. A., Patel, S. R., Schwarz, E. A., Zanzonico, P., Hahn, R. T., Ilercil, A., Devereux, R. B., Goldsmith, S. J., Christian, T. F., Sanborn, T. A., et al. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70455-6 · Cited by 305
Self-citationThe Design of Cationic Lipids for Gene Delivery
Martin, B., Sainlos, M., Aissaoui, A., Oudrhiri, N., Hauchecorne, M., Vigneron, J., Lehn, J., & Lehn, P. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382133 · Cited by 302
Characterization of Cationic Liposome-Mediated Gene Transfer In Vivo by Intravenous Administration
Song, Y. K., Liu, F., Chu, S., & Liu, D. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.13-1585 · Cited by 297
Erbacher, P., Bettinger, T., Belguise-Valladier, P., Zou, S., Coll, J.-L., Behr, J.-P., & Remy, J.-S. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199905/06)1:3<210::aid-jgm30>3.0.co;2-u · Cited by 295
Viral vectors for gene therapy
Robbins, P. D., Tahara, H., & Ghivizzani, S. C. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01137-2 · Cited by 292
Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles
Sokolova, V. V., Radtke, I., Heumann, R., & Epple, M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.12.030 · Cited by 283
Heparan sulfate proteoglycan as a plasma membrane carrier
Belting, M. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00031-8 · Cited by 273
Manipulating Angiogenesis: From Basic Science to the Bedside
Pepper, M. S. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.605 · Cited by 261
Development of lentiviral vectors for gene therapy for human diseases
Buchschacher, G. L., & Wong-Staal, F. (2000) · Blood · doi:10.1182/blood.v95.8.2499 · Cited by 261
Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis
Leopold, P. L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K. K., Rodriguez-Boulan, E., & Crystal, R. G. (2000) · Human Gene Therapy · doi:10.1089/10430340050016238 · Cited by 254
“For use in gene transfer, Ad vectors have typically been constructed from subgroup C, serotype 2 or serotype 5 viruses (Crystal, 1995).”
Self-citationAdenoviral Vector Immunity: Its Implications and Circumvention Strategies
S. Ahi, Y., S. Bangari, D., & K. Mittal, S. (2011) · Current Gene Therapy · doi:10.2174/156652311796150372 · Cited by 185
Tseng, W.-C., Haselton, F. R., & Giorgio, T. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25641 · Cited by 182
Hao, Z., Wang, S., Zhang, X., & Lu, J. (2016) · Cell Proliferation · doi:10.1111/cpr.12242 · Cited by 88
Hahn, C. N., del Pilar Martin, M., Zhou, X.-Y., Mann, L. W., & d’Azzo, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14880 · Cited by 56
Tenkumo, T., Vanegas Sáenz, J. R., Nakamura, K., Shimizu, Y., Sokolova, V., Epple, M., Kamano, Y., Egusa, H., Sugaya, T., & Sasaki, K. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2018.06.047 · Cited by 46
Metadata
- Authors
- Crystal, R. G.
- Venue
- Science
- Published
- 1995-10-20
- Volume
- 270
- Issue
- 5235
- Pages
- 404-410
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2090781939
- Cited by
- 1,000
- References
- 40
- FWCI
- 49.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.